Stay updated on KY1005 in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the KY1005 in Atopic Dermatitis Clinical Trial page.

Latest updates to the KY1005 in Atopic Dermatitis Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedBoth screenshots show the same Study Details page with layout and styling adjustments only; core study information such as eligibility criteria, outcomes, and enrollment remains unchanged.SummaryDifference0.4%

- Check15 days agoNo Change Detected
- Check36 days agoChange Detected- Upgraded to v3.2.0 and removed v3.1.0. - Added a prominent notice about funding-related downtime, possible processing delays, and where to check current operating status (cc.nih.gov and opm.gov).SummaryDifference4%

- Check43 days agoChange DetectedAdded revision label v3.1.0; removed several MedlinePlus topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and the older revision note v3.0.2.SummaryDifference0.6%

- Check58 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' element has been removed.SummaryDifference0.2%

- Check65 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.SummaryDifference0.2%

- Check72 days agoChange DetectedThe web page has undergone significant updates, including the addition of new facility names and locations in Poland, as well as important topics related to drug safety and counterfeit drugs. However, several previous location-related terms and specific medical topics have been removed.SummaryDifference3%

Stay in the know with updates to KY1005 in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KY1005 in Atopic Dermatitis Clinical Trial page.